Publications
Lowe GC, Saavedra A, Reed KB, Velazquez AI, Dronca RS, Markovic SN, Lohse CM, Brewer JD. Increasing incidence of melanoma among middle-aged adults: an epidemiologic study in Olmsted County, Minnesota. Mayo Clinic proceedings. 2014. PMID: 24388022
Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AK, Holmes HM, Jagsi R, Karlekar MB, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Weir AB, Bergman MA, Sundar H. Senior adult oncology, version 2.2014: clinical practice guidelines in oncology . Journal of the National Comprehensive Cancer Network : JNCCN. 2014. PMID: 24453295
Kalet A, Chou CL (eds). Remediation in Medical Education: A Mid-Course Correction Remediation in Medical Education: A Mid-Course Correction. 2014. PMID:
Maa J, Waterford S, Jahan T, Larson DA, Chou D. A novel use of foley catheters to prevent injury to the pelvic viscera during stereotactic radiosurgery for undifferentiated pleomorphic sarcoma of the sacrum. The Permanente journal. 2014. PMID: 25102522
Manuel G. Afable II, Michael J. Clemente, Andres Jerez, Li Zhang, Holleh Husseinzadeh, Hanna Rajala, Satu Mustjoki, Hideki Makishima, Brittney E. Dienes, John Desamito, Alan Lichtin, Mikkael A. Sekeres, Brad Pohlman, Anjali Advani, Ramon V. Tiu, Jaroslaw P. Maciejewski.. Large Granular Lymphocytic: Common Therapies and their Outcomes Journal of Hematology and Transfusion. 2014. PMID:
Okimoto RA, Bivona TG. Recent advances in personalized lung cancer medicine. Personalized medicine. 2014. PMID: 25506379
Riess JW, Nagpal S, Iv M, Zeineh M, Gubens MA, Ramchandran K, Neal JW, Wakelee HA. Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era. Clinical lung cancer. 2014. PMID: 24524822
Venook AP, Weiser MR, Tepper JE. Colorectal cancer: all hands on deck. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2014. PMID: 24857064
Ko AH. Expanding options for pancreatic cancer... so where do we go from here? Volume 28 of Issue 1 Oncology (Williston Park, N.Y.). 2014. PMID: 24683713
Penny K. Sneed, Norbert Kased, James L. Rubenstein. 50 Brain Metastases and Neoplastic Meningitis. . 2014. PMID:
Agnieszka Korfel, James Rubenstein, German Ott, Eric D. Hsi. CNS Lymphoma. Rare Lymphomas. 2014. PMID:
Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O'Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D. Survivorship: introduction and definition. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2014. PMID: 24453291
Beck JT, Hortobagyi GN, Campone M, Lebrun F, Deleu I, Rugo HS, Pistilli B, Masuda N, Hart L, Melichar B, Dakhil S, Geberth M, Nunzi M, Heng DY, Brechenmacher T, El-Hashimy M, Douma S, Ringeisen F, Piccart M. Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2. Breast cancer research and treatment. 2013. PMID: 24362951
Asmussen J, Lasater EA, Tajon C, Oses-Prieto J, Jun YW, Taylor BS, Burlingame A, Craik CS, Shah NP. MEK-dependent negative feedback underlies BCR-ABL-mediated oncogene addiction. Cancer discovery. 2013. PMID: 24362263
Friedlander TW, Premasekharan G, Paris PL. Looking back, to the future of circulating tumor cells. Pharmacology & therapeutics. 2013. PMID: 24362084
Dhruva A, Hecht FM, Miaskowski C, Kaptchuk TJ, Bodeker G, Abrams D, Lad V, Adler SR. Correlating traditional Ayurvedic and modern medical perspectives on cancer: results of a qualitative study. Journal of alternative and complementary medicine (New York, N.Y.). 2013. PMID: 24341342
Verstovsek S, Tam CS, Wadleigh M, Sokol L, Smith CC, Bui LA, Song C, Clary DO, Olszynski P, Cortes J, Kantarjian H, Shah NP. Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitor. Leukemia Research. 2013. PMID: 24374145
Smith CC. Disease diversity and FLT3 mutations. Proceedings of the National Academy of Sciences of the United States of America. 2013. PMID: 24324154
Merriman JD, Aouizerat BE, Cataldo JK, Dunn L, Cooper BA, West C, Paul SM, Baggott CR, Dhruva A, Kober K, Langford DJ, Leutwyler H, Ritchie CS, Abrams G, Dodd M, Elboim C, Hamolsky D, Melisko M, Miaskowski C. Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer. Cytokine. 2013. PMID: 24315345
Politi J, Shah NP. What does a deep molecular response signify? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013. PMID: 24297955